The 5th Congress on Controversies in Leukemias (EUROLEUK 2024)

The 5th Congress on Controversies in Leukemias (EUROLEUK 2024) is focused on basic science to clinical and therapeutic applications and perspectives.

Topics

• Leukemia stem cells (LSCs)
• Biology of ALL, AML, CML, CLL
• Allogeneic hematopoietic stem cell transplantation
• Routing diagnosis gene expression and mutational profiling
• Treatment of resistant/relapsed disease
• Front-line treatment of ALL, AML, CML, CLL
• Immunotherapy
• How novel agents are changing the treatment landscape of ALL, AML, CML and CLL
• Minimal residual disease

Who should Attend

• Biologists (BS)
• Senior or junior clinicians (MD, PhD, MD-PhD)
• R&D personnel
• Clinical residents in-training
• Pharmaceutical and industry professionals